GO:0044721 protein import into peroxisome matrix, substrate release

Peroxisomes are single-membrane organelles essential for lipid metabolism, reactive oxygen species homeostasis, and the synthesis of ether phospholipids. Most peroxisomal matrix proteins are synthesized in the cytosol and imported post-translationally by a dedicated machinery that recognizes peroxisomal targeting signals (PTS1 or PTS2). The import receptor PEX5 recognizes PTS1-bearing cargo proteins and delivers them to the peroxisomal membrane, where a large translocon assembly mediates their translocation. The final step of this process, the release of the cargo protein into the peroxisomal matrix, is annotated as GO:0044721, protein import into peroxisome matrix, substrate release. This step is critical because it determines whether imported proteins become functional within the organelle or remain trapped in the import machinery. The peroxisomal matrix protein translocon is a large cavity-forming protein assembly into which PEX5 protein enters to release its cargo. Understanding the molecular details of substrate release is essential for deciphering peroxisomal biogenesis and for developing therapeutic strategies for peroxisome-related diseases. Research on GO:0044721 has been advanced by structural, biochemical, and genetic studies, including the characterization of PEX5 ubiquitination and its role in receptor recycling. This article provides a comprehensive overview of the definition, mechanism, key genes, disease relevance, and research methods associated with GO:0044721, with a focus on how CRISPR-based models can be used to study this process.

GO:0044721, protein import into peroxisome matrix, substrate release, is defined as the process by which the cargo protein is released into the peroxisomal matrix, following translocation across the membrane. In simpler terms, it is the step where a protein that has been carried into the peroxisome by the import receptor PEX5 is let go inside the organelle so it can perform its function.

GO:0044721 is a critical step in peroxisomal matrix protein import because it ensures that newly imported proteins are released from the import receptor and become functionally active within the peroxisomal matrix. Without proper substrate release, peroxisomes cannot carry out essential metabolic functions such as fatty acid oxidation and plasmalogen synthesis, leading to severe cellular dysfunction. Moreover, the release step is tightly linked to receptor recycling and quality control, as defects in this process can cause the accumulation of import intermediates and trigger proteasomal degradation of PEX5. Thus, understanding GO:0044721 is fundamental for both basic cell biology and for elucidating the molecular basis of peroxisomal disorders.

The following genes and proteins are central to the process of protein import into peroxisome matrix, substrate release (GO:0044721), based on published literature.

The process of protein import into peroxisome matrix, substrate release is regulated at multiple levels. Cysteine-specific ubiquitination of PEX5 is a key regulatory event that protects the receptor against proteasomal degradation and is required for its recycling after cargo release. This ubiquitination is mediated by the RING-finger peroxins PEX2, PEX10, and PEX12, which form a ubiquitin ligase complex at the peroxisomal membrane. Additionally, the AAA-ATPases PEX1 and PEX6, together with PEX26, extract ubiquitinated PEX5 from the membrane, allowing it to be reused. The redox state of the cell and the availability of ATP also influence the efficiency of cargo release and receptor recycling. Furthermore, the expression levels of peroxins and cargo proteins can affect the overall import rate, and mutations in these genes lead to peroxisome biogenesis disorders.

Mutations in genes encoding peroxins, such as PEX1, PEX6, PEX5, PEX13, and PEX2, cause peroxisome biogenesis disorders, including Zellweger spectrum disorders. These diseases are characterized by defective peroxisomal matrix protein import, leading to multi-organ dysfunction, neurological impairment, and early death. Defects in the substrate release step (GO:0044721) can result in the accumulation of import intermediates and impaired peroxisomal metabolism.

Impaired peroxisomal import contributes to oxidative stress and neurodegeneration, as peroxisomes are critical for detoxifying reactive oxygen species and metabolizing very long-chain fatty acids. Defects in PEX5 ubiquitination and recycling can exacerbate cellular stress and lead to neuronal damage. Research on GO:0044721 may provide insights into the molecular mechanisms linking peroxisomal dysfunction to neurodegenerative diseases.

Alterations in peroxisomal function, including protein import, have been observed in various cancers, where metabolic reprogramming supports tumor growth. Although direct links between GO:0044721 and cancer are still emerging, studying the import machinery may reveal vulnerabilities in cancer cells that rely on peroxisomal metabolism.

Fluorescence microscopy using GFP-tagged cargo proteins or PEX5 can visualize the import process and cargo release in real time. Co-localization with peroxisomal markers (e.g., PMP70) confirms matrix delivery. Live-cell imaging of tagged PEX5 has been used to study its insertion into the translocon and release of cargo.

Subcellular fractionation followed by immunoblotting can separate cytosolic and peroxisomal fractions to assess import efficiency. Proteomic approaches can identify cargo proteins and post-translational modifications of PEX5, such as ubiquitination. Mass spectrometry can map ubiquitination sites on PEX5 after cargo release.

CRISPR knockout or knockdown screens targeting peroxins and related genes can identify factors required for substrate release. Such screens have been used to dissect the peroxisomal import pathway. Reporter cell lines expressing a PTS1-GFP fusion can be used to monitor import defects by flow cytometry or microscopy.

In vitro import assays using purified peroxisomes and radiolabeled or fluorescent cargo proteins can reconstitute the release step. These assays allow the study of ATP dependence and the role of individual peroxins. Such systems have been valuable for defining the minimal components required for cargo release.

Researchers studying protein import into peroxisome matrix, substrate release-related genes often need to determine whether a candidate gene is causally involved in the import process or whether its manipulation affects peroxisomal function. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and knock-in of reporter tags.

GO:0044721, protein import into peroxisome matrix, substrate release, is a fundamental step in peroxisomal biology that ensures cargo proteins are delivered into the organelle matrix. The process is mediated by a sophisticated translocon machinery and regulated by ubiquitination and ATP-dependent receptor recycling. Defects in this pathway cause severe peroxisome biogenesis disorders, underscoring its biomedical importance. Advances in CRISPR-based models and imaging technologies continue to illuminate the molecular details of cargo release, offering new opportunities for therapeutic intervention. EDITGENE's suite of CRISPR services can empower researchers to dissect this process with precision and efficiency.